A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Children With Achondroplasia
Clinical trial NCT05598320 · COMPLETED
Trial details
- NCT number
- NCT05598320
- Sponsor
- Ascendis Pharma Growth Disorders A/S
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-03
- Primary completion
- 2024-08-09
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.